275 related articles for article (PubMed ID: 19853220)
1. Identification of pharmacoresistant epilepsy.
Berg AT
Neurol Clin; 2009 Nov; 27(4):1003-1013. PubMed ID: 19853220
[TBL] [Abstract][Full Text] [Related]
2. Predicting pharmacoresistance in pediatric epilepsy.
Wirrell EC
Epilepsia; 2013 May; 54 Suppl 2():19-22. PubMed ID: 23646966
[TBL] [Abstract][Full Text] [Related]
3. [Drug-resistant epilepsy].
Nakken KO; Taubøll E
Tidsskr Nor Laegeforen; 2009 Oct; 129(19):1986-9. PubMed ID: 19823202
[TBL] [Abstract][Full Text] [Related]
4. FALSE PHARMACORESISTANCE - A TRUE PROBLEM.
Bašić S; Marković I; Sporiš D; Šušak Sporiš I; Đerke F; Mrđen I
Acta Clin Croat; 2021 Dec; 60(Suppl 3):9-15. PubMed ID: 36405004
[TBL] [Abstract][Full Text] [Related]
5. Pharmacoresistance and the role of surgery in difficult to treat epilepsy.
Wiebe S; Jette N
Nat Rev Neurol; 2012 Dec; 8(12):669-77. PubMed ID: 22964510
[TBL] [Abstract][Full Text] [Related]
6. Use of verapamil as a potential P-glycoprotein inhibitor in a patient with refractory epilepsy.
Summers MA; Moore JL; McAuley JW
Ann Pharmacother; 2004 Oct; 38(10):1631-4. PubMed ID: 15328394
[TBL] [Abstract][Full Text] [Related]
7. The intrinsic severity hypothesis of pharmacoresistance to antiepileptic drugs.
Rogawski MA
Epilepsia; 2013 May; 54 Suppl 2():33-40. PubMed ID: 23646969
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of pharmacoresistant epilepsy: stimulated refractoriness].
Rossetti AO; Vulliémoz S
Rev Med Suisse; 2012 May; 8(339):930, 932-4. PubMed ID: 22675822
[TBL] [Abstract][Full Text] [Related]
9. Diagnosing and predicting refractory epilepsy.
Brodie MJ
Acta Neurol Scand Suppl; 2005; 181():36-9. PubMed ID: 16238707
[TBL] [Abstract][Full Text] [Related]
10. Pharmacology aspects during transition and at transfer in patients with epilepsy.
Chiron C; An I
Epilepsia; 2014 Aug; 55 Suppl 3():8-11. PubMed ID: 25209078
[TBL] [Abstract][Full Text] [Related]
11. Defining intractable epilepsy.
Berg AT
Adv Neurol; 2006; 97():5-10. PubMed ID: 16383109
[TBL] [Abstract][Full Text] [Related]
12. Is routine electroencephalography (EEG) a useful biomarker for pharmacoresistant epilepsy?
Steinhoff BJ; Scholly J; Dentel C; Staack AM
Epilepsia; 2013 May; 54 Suppl 2():63-6. PubMed ID: 23646974
[TBL] [Abstract][Full Text] [Related]
13. Definition of intractable epilepsy.
Sinha S; Siddiqui KA
Neurosciences (Riyadh); 2011 Jan; 16(1):3-9. PubMed ID: 21206438
[TBL] [Abstract][Full Text] [Related]
14. [Refractory epilepsy: use of the new definition and related risk factors. A study in the Mexican population of a third-level centre].
Martínez-Juárez IE; López-Zapata R; Gómez-Arias B; Bravo-Armenta E; Romero-Ocampo L; Estévez-Cruz Z; Hernández-De la Cruz G; Morán-Molina S
Rev Neurol; 2012 Feb; 54(3):159-66. PubMed ID: 22278892
[TBL] [Abstract][Full Text] [Related]
15. Pharmacoresistant epilepsy: from pathogenesis to current and emerging therapies.
Pati S; Alexopoulos AV
Cleve Clin J Med; 2010 Jul; 77(7):457-67. PubMed ID: 20601619
[TBL] [Abstract][Full Text] [Related]
16. Predictive factors for early identification of pharmacoresistant epilepsy.
Sporis D; Basić S; Susak I; Colak Z; Marković I
Acta Clin Croat; 2013 Mar; 52(1):11-5. PubMed ID: 23837267
[TBL] [Abstract][Full Text] [Related]
17. Off-label prescribing of antiepileptic drugs in pharmacoresistant epilepsy: a cross-sectional drug utilization study of tertiary care centers in Italy.
Franco V; Canevini MP; Capovilla G; De Sarro G; Galimberti CA; Gatti G; Guerrini R; La Neve A; Rosati E; Specchio LM; Striano S; Tinuper P; Perucca E
CNS Drugs; 2014 Oct; 28(10):939-49. PubMed ID: 25056568
[TBL] [Abstract][Full Text] [Related]
18. Is pseudo-intractability in population of patients with epilepsy still alive in the 21st century? Audit of 100 seizure-free patients, referred with the diagnosis of pharmacoresistant epilepsy.
Bajacek M; Hovorka J; Nezadal T; Nemcova I; Herman E
Neuro Endocrinol Lett; 2010; 31(6):818-22. PubMed ID: 21196921
[TBL] [Abstract][Full Text] [Related]
19. Role of multidrug transporters in pharmacoresistance to antiepileptic drugs.
Löscher W; Potschka H
J Pharmacol Exp Ther; 2002 Apr; 301(1):7-14. PubMed ID: 11907151
[TBL] [Abstract][Full Text] [Related]
20. EEG abnormalities as a biomarker for cognitive comorbidities in pharmacoresistant epilepsy.
Holmes GL
Epilepsia; 2013 May; 54 Suppl 2(0 2):60-2. PubMed ID: 23646973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
